<DOC>
	<DOCNO>NCT02094157</DOCNO>
	<brief_summary>Approximately 2 million patient North America currently treat blood thinner warfarin . These patient every year 200,000 invasive procedure , warfarin must stop avoid bleed complication . To protect patient blood clot stroke warfarin stop , physician today order `` bridging '' low-molecular-weight heparin ( LMWH ) . This another blood thinner inject skin 3 day procedure . For implantation pacemaker defibrillator ( 27,000/year Canada ) `` bridge '' routine vary lot.The common `` bridging '' treatment LMWH 3 day pacemaker surgery cause bleed `` pocket '' pacemaker place 5 % . For comparison , patient blood thinner develop bleed 2 % surgery . `` Pocket bleeding '' may require evacuation blood collection may cause infection . `` Pocket bleeding '' thus fairly common clinically important rarely dangerous bleed complication . It suitable safety endpoint study `` bridging '' blood thinner . LMWH cost $ 80-120 , patient cover . They teach self-injection technique nurse come home . The main hypothesis patient blood thinner manage conveniently pacemaker surgery , without injection , without increase risk pocket bleeding .</brief_summary>
	<brief_title>Tapered Warfarin Interrupted Warfarin With Heparin Bridging Pacemaker Defibrillator Implantation</brief_title>
	<detailed_description>Patients recruit routinely refer surgery adjustment blood thinner . Suitable consent patient randomize one two regimen . They either stop warfarin 5 day replace injection LMWH 3 day pacemaker implantable cardioverter defibrillator ( ICD ) surgery . The group dose warfarin reduce half 3-6 day surgery , depend thin blood . For patient degree blood thinning check day surgery . If blood still thin , patient instruct take mouth dose vitamin K , provide u , reduce effect warfarin . After surgery patient restart warfarin double dose 1 2 day quickly reach therapeutic effect . Staff Pacemaker Defibrillator Clinic , unaware treatment allocation , examines patient bleed implantation pocket leave hospital , routine follow-up 2-3 week 90 day .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>The patient receive warfarin therapy least 1 week plan continue treatment least one month postprocedure The patient elective implantation replacement pacemaker ICD Age &lt; 18 year Previous stroke Stroke risk ( CHADS2 ) score 0 1 patient atrial fibrillation indication anticoagulation Creatinine clearance ( CrCl ) &lt; 30 mL/min Surgery plan Monday day holiday Patient unsuitable study assess investigator ( e.g. , psychiatric disorder , history noncompliance ) Failure obtain write consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Mechanical heart valve</keyword>
	<keyword>Stroke</keyword>
	<keyword>Venous thromboembolism</keyword>
	<keyword>Hemorrhage</keyword>
</DOC>